Literature DB >> 11070028

A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant.

S Piyasirisilp1, F E McCutchan, J K Carr, E Sanders-Buell, W Liu, J Chen, R Wagner, H Wolf, Y Shao, S Lai, C Beyrer, X F Yu.   

Abstract

New outbreaks of human immunodeficiency virus type 1 (HIV-1) among injecting drug users (IDUs) are spreading in China along heroin trafficking routes. Recently, two separate HIV-1 epidemics among IDUs were reported in Guangxi, Southern China, where partial sequencing of the env gene showed subtype C and circulating recombinant form (CRF) AE. We evaluated five virtually full-length HIV-1 genome sequences from IDUs in Guangxi to determine the genetic diversity and the presence of intersubtype recombinants. Sequence analysis showed two geographically separated, highly homogeneous HIV-1 strains. B/C intersubtype recombinants were found in three IDUs from Baise City, in a mountainous region near the Yunnan-Guangxi border. These were mostly subtype C, with portions of the capsid and reverse transcriptase (RT) genes from subtype B. The subtype B portion of the capsid was located in the N-terminal domain, which has been shown to influence virus core maturation, virus infectivity, and binding to cyclophilin A, whereas the subtype B portion of RT was located in the palm subdomain, which is the active site of the enzyme. These BC recombinants differed from a BC recombinant found in Xinjiang Province in northwestern China. CRF AE strains were found in IDUs from Nanning, the capital of Guangxi, and in IDUs from Pingxiang City near the China-Vietnam border. The AE and BC recombinants were both remarkable for their low interpatient diversity, less than 1% for the full genome. Rapid spread of HIV-1 among IDUs may foster the emergence of highly homogeneous strains, including novel recombinants in regions with multiple subtypes.

Entities:  

Mesh:

Year:  2000        PMID: 11070028      PMCID: PMC113233          DOI: 10.1128/jvi.74.23.11286-11295.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Characterization of subtype A HIV-1 from Africa by full genome sequencing.

Authors:  J K Carr; T Laukkanen; M O Salminen; J Albert; A Alaeus; B Kim; E Sanders-Buell; D L Birx; F E McCutchan
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

2.  Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Authors:  V A Novitsky; M A Montano; M F McLane; B Renjifo; F Vannberg; B T Foley; T P Ndung'u; M Rahman; M J Makhema; R Marlink; M Essex
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  HIV type 1 subtypes in Guangxi Province, China, 1996.

Authors:  J Chen; N L Young; S Subbarao; P Warachit; S Saguanwongse; S Wongsheree; C Jayavasu; C C Luo; T D Mastro
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-01       Impact factor: 2.205

4.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia.

Authors:  C Beyrer; M H Razak; K Lisam; J Chen; W Lui; X F Yu
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

5.  The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.

Authors:  R B Oelrichs; I L Shrestha; D A Anderson; N J Deacon
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections.

Authors:  V V Lukashov; R Huismans; A G Rakhmanova; Z N Lisitsina; N A Akhtyrskaya; N N Vlasov; O B Melnick; J Goudsmit
Journal:  AIDS Res Hum Retroviruses       Date:  1999-11-20       Impact factor: 2.205

7.  An HIV type 1 subtype A outbreak among injecting drug users in Latvia.

Authors:  A Ferdats; V Konicheva; I Dievberna; E Lilja; J Albert
Journal:  AIDS Res Hum Retroviruses       Date:  1999-11-01       Impact factor: 2.205

8.  Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China.

Authors:  X F Yu; J Chen; Y Shao; C Beyrer; B Liu; Z Wang; W Liu; J Yang; S Liang; R P Viscidi; J Gu; G Gurri-Glass; S Lai
Journal:  J Acquir Immune Defic Syndr       Date:  1999-10-01       Impact factor: 3.731

9.  Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China.

Authors:  K Kato; T Shiino; S Kusagawa; H Sato; K Nohtomi; K Shibamura; T H Nguyen; K C Pham; X L Truong; H A Mai; T L Hoang; G Bunyaraksyotin; Y Fukushima; M Honda; C Wasi; S Yamazaki; Y Nagai; Y Takebe
Journal:  AIDS Res Hum Retroviruses       Date:  1999-09-01       Impact factor: 2.205

10.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

View more
  94 in total

1.  Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon.

Authors:  Jiangqin Zhao; Shixing Tang; Viswanath Ragupathy; Jean K Carr; Nathan D Wolfe; Bih Awazi; Indira Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

2.  Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.

Authors:  Sihong Xu; Aijing Song; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

3.  Risk of HIV/AIDS in China: subpopulations of special importance.

Authors:  H Z Qian; Z H Qian; S H Vermund; N Wang
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

Review 4.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

Review 5.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Magdalena E Sobieszczyk; Francine E McCutchan; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

6.  Near full-length genome identification of a novel HIV type 1 B'/C recombinant isolate JL100091 in Jilin, China.

Authors:  Chuanyi Ning; Xingguang Li; Xiang He; Hui Xing; Kunxue Hong; Rongge Yang; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-19       Impact factor: 2.205

7.  Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.

Authors:  Sihong Xu; Ping Zhong; Jingyun Li; Aijing Song; Hanping Li; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-02-01       Impact factor: 4.074

8.  In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.

Authors:  Hao Wu; Xiao-Min Zhang; Hao-Jie Zhang; Qiwei Zhang; Zhiwei Chen; Jian-Dong Huang; Shui-Shan Lee; Bo-Jian Zheng
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-08       Impact factor: 2.205

9.  CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Authors:  Awet Abraha; Immaculate L Nankya; Richard Gibson; Korey Demers; Denis M Tebit; Elizabeth Johnston; David Katzenstein; Asna Siddiqui; Carolina Herrera; Lucia Fischetti; Robin J Shattock; Eric J Arts
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China.

Authors:  Hong Shang; Ping Zhong; Jing Liu; Xiaoxu Han; Di Dai; Min Zhang; Ke Zhao; Rongzhen Xu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.